Xeris Pharmaceuticals | XERS - Ebitda

股票价格
6.05
每天变化
0.10 1.68%
每月一次
14.15%
每年
40.37%
Q2 预测
5.92


金融业
股票价格
USD
资产
USD 383.53M
现金及等价物
USD 111.04M
销售成本
USD 13.66M
流动资产
USD 240.31M
流动负债
USD 109.57M
债务
USD 257.65M
EBIT
USD 16.77M
EBITDA
USD 25.09M
员工
377
EPS每股收益
USD 0.05
股本和储备
USD 13.69M
销售毛利
USD 72.15M
债务利息支出
USD 7.15M
利息收入
USD 1.16M
贷款资金
USD 220.34M
市值
USD 835.7M
净收入
USD 11.08M
营业费用
USD 69.03M
营业利润
USD 16.77M
普通股股本
USD 166.22M
PE价格收益
2.45K
税前利润
USD 11.08M
销售收入
USD 85.81M
销售和管理费用
USD 42.64M
股票
USD 68.67M
贸易债权人
USD 3.08M
应收帐款人
USD 51.05M


Ebitda 更改 日
Celltrion KRW 374.56B 352.67B 2025-09
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Divis Laboratories Ltd INR 8.9B 20M 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Kangmei Pharma CNY 17.3M 20.56M 2025-06
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organigram Holdings CAD 5.26M 884K 2025-12
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pharma Mar EUR 44.96M 46.94M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
Tilray USD 8.36M 1.82M 2025-09
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M 2025-06